Further, CTA expression in breast cancer has been shown to elicit a broad range of cellular and humoral immune responses [50, 52, 53]; both CD8+ T cell and CD79+ B cell infiltration has been observed in primary and metastatic NY-ESO-1 expressing breast cancer [54]. Here, CD8A is linked to breast carcinoma.